Jakub Szwed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jakub Szwed has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Monika Szwed
Provincial Specialist Hospital of the name Stefan Cardinal Wyszyński, Aleja Kraśnicka 100, 20-718 Lublin
5 shared publications - Jerzy Mosiewicz
Department of Internal Diseases, Medical University, Lublin, Poland
2 shared publications - Lech Panasiuk
Institute of Rural Health, Lublin, Poland
2 shared publications - Nadia Miga-Orczykowska
Stefan Wyszyński Provincial Specialist Hospital in Lublin, Aleja Kraśnicka 100, 20-718 Lublin, Poland
2 shared publications - Weronika Szwed
Provincial Specialist Hospital in Olsztyn, Żołnierska 18, 10-561 Olsztyn, Poland
2 shared publications - Wojciech Myśliński
Chair and Department of Internal Medicine, Medical University, Lublin, Poland
2 shared publications
Latest Publications
- Open Access
- 22 December 2022
- Published by Institute of Rural Health in Annals of Agricultural and Environmental Medicine
- Vol. 29 (4) , 588-591
Comparison of health care systems in Poland and Great Britain by Poles staying temporarily in Great Britain prior to the COVID pandemic
Introduction: Poland’s accession to the European Union intensified migration for work purposes. One of the most popular destinations for emigration was Great Britain, which allocates more money to health protection than Poland, where there is a widespread belief that the quality of public...
- 22 December 2022
- Published by Institute of Rural Health in Annals of Agricultural and Environmental Medicine
- Vol. 29 (4) , 588-591
Open AccessComparison of health care systems in Poland and Great Britain by Poles staying temporarily in Great Britain prior to the COVID pandemic
Introduction: Poland’s accession to the European Union intensified migration for work purposes. One of the most popular destinations for emigration was Great Britain, which allocates more money to health protection than Poland, where there is a widespread belief that the quality of public...
- Open Access
- 25 May 2022
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 12 (8) , 1026-1036
The use of botulinum toxin (BoNT) in urology - review
Introduction and purpose Botulinum neurotoxin (BoNT) prevents the release of acetylcholine into the synaptic cleft of the neuromuscular junction, which causes flaccid muscle paralysis. A non-obvious specialization that uses botulinum toxin is urology. The aim of this article is to present a literature review regarding the use of botulinum toxin in the treatment of urological diseases. Description of the state of knowledge In the overactive bladder syndrome, with resistance to oral medications, an alternative is botox injections into the bladder wall, which reduce the intensity of urgency and pollakiuria. Treatment of BPH with botulinum toxin injection may be an alternative to surgical and pharmacological treatment. Intra-articular botox injection causes smooth muscle relaxation and gland atrophy through prostate tissue apoptosis. Clinical studies show promising therapeutic effects of using Botox injections in the treatment of intramural cystitis. It reduces the feeling of bladder pain and the worsening of other symptoms. Panunzio et al. Presented a meta-analysis of prospective studies that showed a statistically significant improvement in pain perception after injection of botulinum toxin into the pelvic structures, compared with baseline values for CPPS, in all cohorts evaluated. Summary Urology uses the entire spectrum of botox possibilities, from myocrelation in the bladder hyperresponsiveness syndrome, through neuromodulation and apoptosis induction in benign prostatic hyperplasia, ending with anti-inflammatory and analgesic properties in bladder pain syndrome and chronic pelvic pain syndrome.
- 25 May 2022
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 12 (8) , 1026-1036
Open AccessThe use of botulinum toxin (BoNT) in urology - review
Introduction and purpose Botulinum neurotoxin (BoNT) prevents the release of acetylcholine into the synaptic cleft of the neuromuscular junction, which causes flaccid muscle paralysis. A non-obvious specialization that uses botulinum toxin is urology. The aim of this article is to present a literature review regarding the use of botulinum toxin in the treatment of urological diseases. Description of the state of knowledge In the overactive bladder syndrome, with resistance to oral medications, an alternative is botox injections into the bladder wall, which reduce the intensity of urgency and pollakiuria. Treatment of BPH with botulinum toxin injection may be an alternative to surgical and pharmacological treatment. Intra-articular botox injection causes smooth muscle relaxation and gland atrophy through prostate tissue apoptosis. Clinical studies show promising therapeutic effects of using Botox injections in the treatment of intramural cystitis. It reduces the feeling of bladder pain and the worsening of other symptoms. Panunzio et al. Presented a meta-analysis of prospective studies that showed a statistically significant improvement in pain perception after injection of botulinum toxin into the pelvic structures, compared with baseline values for CPPS, in all cohorts evaluated. Summary Urology uses the entire spectrum of botox possibilities, from myocrelation in the bladder hyperresponsiveness syndrome, through neuromodulation and apoptosis induction in benign prostatic hyperplasia, ending with anti-inflammatory and analgesic properties in bladder pain syndrome and chronic pelvic pain syndrome.
- Open Access
- 25 May 2022
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 12 (8) , 714-721
Botulinum toxin (BoNT) in the correction of mimic wrinkles - the most common complications
Introduction and purpose Botulinum toxin (BoNT) products are commonly used to treat muscle spasms such as cervical dystonia as well as to treat expression lines. Serotype A of botulinum toxin is the strongest and is used in aesthetic medicine procedures. It provides predictable results while having few side effects. Nevertheless, complications may occur, such as: ptosis of the upper eyelid, drooping eyebrows, ectropia, double vision, xerophthalmia, falling corners of the mouth, dysphagia, hoarseness, local swelling, erythema, bruising, pain at the injection site, asymmetry. The aim of the study is to discuss the most common complications after injection of the botulin toxin in the correction of mimic wrinkles. Description of the state of knowledge BoNT is a neurotoxin that acts on the neuromuscular junctions, inhibits the release of acetylcholine, consequently causing temporary chemical denervation. Muscle function begins to return approximately 3 months after injection and fully returns after 6 months. Comparison of clinical trials of botulinum toxin type A in aesthetic allowed for the quantification of the frequency of adverse effects:drooping eyelids (2.5%), drooping eyebrows (3.1%), disturbed eye sensation (3%) and lip asymmetry (6.9%). Complications after cosmetic botulinum toxin injections are rare, and those that do occur are usually mild and transient. These complications are technique dependent; the incidence decreases as the injection ability improves. Summary Side effects are rare, nevertheless, thorough knowledge of the patient's anatomy, medical history, possible complications related to the specific product and site of administration, and close monitoring are essential for safe, effective treatment and the achievement of satisfactory results.
- 25 May 2022
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 12 (8) , 714-721
Open AccessBotulinum toxin (BoNT) in the correction of mimic wrinkles - the most common complications
Introduction and purpose Botulinum toxin (BoNT) products are commonly used to treat muscle spasms such as cervical dystonia as well as to treat expression lines. Serotype A of botulinum toxin is the strongest and is used in aesthetic medicine procedures. It provides predictable results while having few side effects. Nevertheless, complications may occur, such as: ptosis of the upper eyelid, drooping eyebrows, ectropia, double vision, xerophthalmia, falling corners of the mouth, dysphagia, hoarseness, local swelling, erythema, bruising, pain at the injection site, asymmetry. The aim of the study is to discuss the most common complications after injection of the botulin toxin in the correction of mimic wrinkles. Description of the state of knowledge BoNT is a neurotoxin that acts on the neuromuscular junctions, inhibits the release of acetylcholine, consequently causing temporary chemical denervation. Muscle function begins to return approximately 3 months after injection and fully returns after 6 months. Comparison of clinical trials of botulinum toxin type A in aesthetic allowed for the quantification of the frequency of adverse effects:drooping eyelids (2.5%), drooping eyebrows (3.1%), disturbed eye sensation (3%) and lip asymmetry (6.9%). Complications after cosmetic botulinum toxin injections are rare, and those that do occur are usually mild and transient. These complications are technique dependent; the incidence decreases as the injection ability improves. Summary Side effects are rare, nevertheless, thorough knowledge of the patient's anatomy, medical history, possible complications related to the specific product and site of administration, and close monitoring are essential for safe, effective treatment and the achievement of satisfactory results.
- Open Access
- 25 May 2022
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 12 (8) , 722-729
HA (hyaluronic acid) fillers in aesthetic medicine - the most common complications
Introduction and purpose Hyaluronic acid (HA) is a polysaccharide consisting of the disaccharide units of glucuronic acid and N-acetylglucosamine. The age-related changes in the different anatomical layers of the face can be treated with hyaluronic acid fillers. Knowing the predictable aging changes of the face is crucial as this guides the optimum filler choice. HA is currently the most common used filler worldwide. The aim of the study is to discuss the most common complications following aesthetic medicine treatments with the use of hyaluronic acid. Description of the state of knowledge Filling soft tissues with hyaluronic acid is a popular procedure in the field of aesthetic medicine for patients who want non-invasive rejuvenation. Among the numerous fillers, those with hyaluronic acid (HA) have many advantages: HA is easy to use and its effect is reversible. HA fillers are considered safe, although there may be complications such as: allergic reactions, infections, granulomas, nodules, tyndall effect, ecchymosis and skin necrosis. Many complications with the HA filler are correctable, for example: too little formulation, over-correctionand, asymmetry. Hyaluronic acid fillers are examples of reversible dermal fillers as they can be removed with hyaluronidase. Summary Avoiding complications is a top priority and must start with a thorough understanding of the anatomy followed by a precise injection technique. The ability to recognize complications and manage protocols will allow for their effective treatment.
- 25 May 2022
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 12 (8) , 722-729
Open AccessHA (hyaluronic acid) fillers in aesthetic medicine - the most common complications
Introduction and purpose Hyaluronic acid (HA) is a polysaccharide consisting of the disaccharide units of glucuronic acid and N-acetylglucosamine. The age-related changes in the different anatomical layers of the face can be treated with hyaluronic acid fillers. Knowing the predictable aging changes of the face is crucial as this guides the optimum filler choice. HA is currently the most common used filler worldwide. The aim of the study is to discuss the most common complications following aesthetic medicine treatments with the use of hyaluronic acid. Description of the state of knowledge Filling soft tissues with hyaluronic acid is a popular procedure in the field of aesthetic medicine for patients who want non-invasive rejuvenation. Among the numerous fillers, those with hyaluronic acid (HA) have many advantages: HA is easy to use and its effect is reversible. HA fillers are considered safe, although there may be complications such as: allergic reactions, infections, granulomas, nodules, tyndall effect, ecchymosis and skin necrosis. Many complications with the HA filler are correctable, for example: too little formulation, over-correctionand, asymmetry. Hyaluronic acid fillers are examples of reversible dermal fillers as they can be removed with hyaluronidase. Summary Avoiding complications is a top priority and must start with a thorough understanding of the anatomy followed by a precise injection technique. The ability to recognize complications and manage protocols will allow for their effective treatment.
- Open Access
- 11 May 2022
- Published by Institute of Rural Health in Annals of Agricultural and Environmental Medicine
- Vol. 29 (2) , 294-299
Prevalence of target organ damage in hypertensive patients with coexisting obstructive sleep apnea
Introduction and objective: Obstructive sleep apnea (OSA) is associated with cardiovascular risk and higher mortality. Assessment of subclinical organ lesions is significant for prevention of clinically manifested complications which might result in death. The aim of the study was to assess the...
- 11 May 2022
- Published by Institute of Rural Health in Annals of Agricultural and Environmental Medicine
- Vol. 29 (2) , 294-299
Open AccessPrevalence of target organ damage in hypertensive patients with coexisting obstructive sleep apnea
Introduction and objective: Obstructive sleep apnea (OSA) is associated with cardiovascular risk and higher mortality. Assessment of subclinical organ lesions is significant for prevention of clinically manifested complications which might result in death. The aim of the study was to assess the...